Breast Cancer Trial, Not Yet Recruiting NCT07313033 Sponsor: Hospices Civils de Lyon Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07313033
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 or older.
  • People who are covered by, or entitled to, a social security system.
  • People who have agreed to take part in the study and have signed a written consent form.
  • People who have had an 18F-FDG PET/CT scan (a type of full-body imaging scan) as part of checking the spread of a specific type of breast cancer called infiltrating lobular carcinoma, where the scan results came back negative or unclear for at least one area of concern.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Women who are pregnant, in labour, or currently breastfeeding. (Women who could become pregnant will be asked to take a pregnancy test before joining.)
  • People who are in custody or detained by a court or government decision.
  • People who are currently receiving psychiatric care.
  • People who are staying in a health or social care facility for reasons unrelated to research.
  • Adults who are under a legal protection arrangement, such as guardianship or curatorship.
  • People who are already taking part in another interventional research study that has an exclusion period that has not yet ended.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 4 72 35 69 99

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 March 2026
Est. completion
30 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage of patients for whom at least one secondary lesion is demonstrated in [68]Ga-FAPI and confirmed by histology, when [18]F-FDG PET/CT is negative

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov